Tonix Pharmaceuticals: Raymond James cuts target price to $14 from $26
TNXP•Raymond James cut its target price for Tonix Pharmaceuticals to $14 from $26.
Related News
McEwen Q3 2026 net loss widens to $36.7 million; revenue falls 14% to $43.6 million
MUX•
Ionis Pharmaceuticals: Canaccord Genuity cuts target price to $72 from $85
IONS•
Qualys raises target price to $220 from $190
QLYS•
Magnolia Oil & Gas Corp: Gerdes Energy Research raises to buy from neutral
MGY•
Leerink Partners cuts Zura Bio target price to $5 from $11
ZURA•